You just read:

European Commission Approves Once-Daily Olumiant Tablets for Treatment of Adults with Moderate-to-Severe Active Rheumatoid Arthritis

News provided by

Eli Lilly and Company; Incyte Corporation

Feb 13, 2017, 15:21 ET